{"database":"biostudies-literature","file_versions":[],"scores":null,"additional":{"omics_type":["Unknown"],"submitter":["Fiedler L"],"funding":["Abbott Laboratories"],"pubmed_abstract":["<h4>Background</h4>We quantified and characterized the outcomes of ablation in persistent atrial fibrillation (PersAF) subjects, and the utility of electroanatomical mapping with a market-released high-density (HD) mapping catheter.<h4>Methods</h4>PersAF subjects received electroanatomical mapping with the Advisor™ HD Grid mapping catheter, Sensor Enabled™ (HD Grid) and radiofrequency (RF) ablation to gather data regarding ablation strategies, mapping efficiency, quality, and outcomes. Subjects were enrolled from January 2019 to April 2020 across 25 international sites and followed for 12 months after the procedure.<h4>Results</h4>Three hundred thirty-four PersAF subjects (average age 64.2 years; 76% male; 25.4% previous AF ablation) were enrolled. Multiple map types were generated in a va"],"journal":["Journal of interventional cardiac electrophysiology : an international journal of arrhythmias and pacing"],"full_dataset_link":["https://www.ebi.ac.uk/biostudies/studies/S-EPMC9735148"],"repository":["biostudies-literature"],"pubmed_title":["Characterization of high-density mapping in catheter ablation for persistent atrial fibrillation: results from the Advisor™ HD Grid Mapping Catheter Observational study."],"pmcid":["PMC9735148"],"pubmed_authors":["Lacotte J","Jesser E","Roithinger FX","Steven D","Haqqani H","Roca I","Fiedler L","Williams C","Lorgat F"],"additional_accession":[]},"is_claimable":false,"name":"Characterization of high-density mapping in catheter ablation for persistent atrial fibrillation: results from the Advisor™ HD Grid Mapping Catheter Observational study.","description":"<h4>Background</h4>We quantified and characterized the outcomes of ablation in persistent atrial fibrillation (PersAF) subjects, and the utility of electroanatomical mapping with a market-released high-density (HD) mapping catheter.<h4>Methods</h4>PersAF subjects received electroanatomical mapping with the Advisor™ HD Grid mapping catheter, Sensor Enabled™ (HD Grid) and radiofrequency (RF) ablation to gather data regarding ablation strategies, mapping efficiency, quality, and outcomes. Subjects were enrolled from January 2019 to April 2020 across 25 international sites and followed for 12 months after the procedure.<h4>Results</h4>Three hundred thirty-four PersAF subjects (average age 64.2 years; 76% male; 25.4% previous AF ablation) were enrolled. Multiple map types were generated in a va","dates":{"release":"2022-01-01T00:00:00Z","publication":"2022 Dec","modification":"2025-04-18T19:20:11.991Z","creation":"2025-04-07T07:00:40.955Z"},"accession":"S-EPMC9735148","cross_references":{"pubmed":["36481832"],"doi":["10.1007/s10840-022-01442-3"]}}